aldose reductase inhibitors (Columbia University/Columbia Technology Ventures)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug Namealdose reductase inhibitors (Columbia University/Columbia Technology Ventures)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsWounds and InjuriesDiabetes ComplicationsCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesColumbia University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColumbia Technology VenturesColumbia University
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesDiabetes ComplicationsCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A